Innovex International (INVX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, to be held virtually for stockholders of record as of March 18, 2025.
Proxy materials, including the notice, proxy statement, and annual report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three director nominees for a three-year term: Terence Jupp, Carri Lockhart, and Jason Turowsky.
Approval sought for an amendment to increase authorized shares of common stock.
Adoption of the 2025 Long-Term Incentive Plan proposed.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2025.
Advisory vote on executive compensation for named executive officers.
Board of directors and corporate governance
Board recommends voting in favor of all proposals on the agenda.
Director nominees identified for election to serve a three-year term.
Latest events from Innovex International
- Q4 revenue up 14% sequentially, strong cash flow, and margin expansion expected in 2026.INVX
Q4 202524 Feb 2026 - Q3 revenue up 17% to $152M; $83M net income and $15M synergies highlight merger impact.INVX
Q3 202415 Jan 2026 - Post-merger registration allows resale of 44% of shares, with no proceeds to the company.INVX
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, share increase, LTIP, auditor, and executive pay.INVX
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, share increase, LTIP, auditor, and say-on-pay votes.INVX
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 58% YoY to $240M, with strong cash flow and major acquisitions completed.INVX
Q3 202513 Nov 2025 - Q2 2025 revenue surged 72% YoY to $224.2M, fueled by acquisitions and global expansion.INVX
Q2 20256 Aug 2025 - Revenue up 34% to $120.3M; Innovex merger expected to close in Q3 2024.INVX
Q2 202413 Jun 2025 - Q1 2025 saw strong growth and cash flow, but margins declined amid integration costs.INVX
Q1 20259 Jun 2025